The Chief Commercial Officer of Veracyte has executed a sale of company stock valued at $699,732. This transaction reflects the ongoing management of personal investment portfolios by the executive. Details regarding the specific number of shares sold or the timing of the sale have not been disclosed. Veracyte, a company specializing in genomic diagnostics, continues to operate within the healthcare sector.
Related Articles
Don't miss out on breaking stories and in-depth articles.